Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Pierce

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|June 7, 2013
Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugsChristopher G Pierce, Jose L Lopez-Ribot
Pathogens and Disease|March 14, 2014
High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentationChristopher G Pierce, Stephen P Saville, Jose L Lopez-Ribot
The Journal of Antimicrobial Chemotherapy|December 23, 2008
Effect of tunicamycin on Candida albicans biofilm formation and maintenanceChristopher G Pierce, Derek P Thomas, José L López-Ribot
Journal of Visualized Experiments : Jove|November 5, 2010
A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilmsChristopher G Pierce, Priya Uppuluri, Sushma Tummala, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2013
In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilmsSemanti Sarkar, Priya Uppuluri, Christopher G Pierce, et al.
Microbiology Spectrum|July 18, 2015
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal BiofilmsChristopher G Pierce, Anand Srinivasan, Anand K Ramasubramanian, et al.
Current Opinion in Pharmacology|September 10, 2013
Antifungal therapy with an emphasis on biofilmsChristopher G Pierce, Anand Srinivasan, Priya Uppuluri, et al.
Revista Iberoamericana De Micologia|June 10, 2026
Clade-dependent antifungal resistance and susceptibility in Candidozyma auris: A global scoping reviewLucero A Martinez Delgado, Christopher G Pierce, Giselle D Carnaby, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2013
High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitorsSamuel A Siles, Anand Srinivasan, Christopher G Pierce, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2009
Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasisAnna L Lazzell, Ashok K Chaturvedi, Christopher G Pierce, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|June 7, 2013
Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugsChristopher G Pierce, Jose L Lopez-Ribot
Pathogens and Disease|March 14, 2014
High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentationChristopher G Pierce, Stephen P Saville, Jose L Lopez-Ribot
The Journal of Antimicrobial Chemotherapy|December 23, 2008
Effect of tunicamycin on Candida albicans biofilm formation and maintenanceChristopher G Pierce, Derek P Thomas, José L López-Ribot
Journal of Visualized Experiments : Jove|November 5, 2010
A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilmsChristopher G Pierce, Priya Uppuluri, Sushma Tummala, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2013
In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilmsSemanti Sarkar, Priya Uppuluri, Christopher G Pierce, et al.
Microbiology Spectrum|July 18, 2015
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal BiofilmsChristopher G Pierce, Anand Srinivasan, Anand K Ramasubramanian, et al.
Current Opinion in Pharmacology|September 10, 2013
Antifungal therapy with an emphasis on biofilmsChristopher G Pierce, Anand Srinivasan, Priya Uppuluri, et al.
Revista Iberoamericana De Micologia|June 10, 2026
Clade-dependent antifungal resistance and susceptibility in Candidozyma auris: A global scoping reviewLucero A Martinez Delgado, Christopher G Pierce, Giselle D Carnaby, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2013
High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitorsSamuel A Siles, Anand Srinivasan, Christopher G Pierce, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2009
Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasisAnna L Lazzell, Ashok K Chaturvedi, Christopher G Pierce, et al.
Pageof 2